AI-Driven IoT (AIIOT) in Brain Health Study

Abstract

Context and Justification The prevalence of neurodegenerative diseases around the world demands a paradigm change from reactive, episodic clinical diagnosis to ongoing, proactive neuro-monitoring. The possibility for early detection and individualized management is limited by the fact that traditional diagnostic techniques sometimes rely on subjective evaluation or costly, intrusive imaging. An unparalleled chance to identify, evaluate, and interpret the subtle, objective indicators of preclinical cognitive alterations is presented by the convergence of the Internet of Things (IoT) and sophisticated artificial intelligence (AI). Methods In order to generate a continuous, longitudinal stream of physiological and behavioural data, this study presents a novel, decentralized platform that makes use of a heterogeneous network of IoT devices, such as high-resolution wearables, smart home sensors, and non-contact physiological monitors (digital phenotyping). Large datasets pertaining to sleep architecture, gait variability, social interaction frequency, and speech hesitancy were analysed using deep learning techniques, particularly convolutional neural networks for anomaly detection in sensor data and long short-term memory (LSTM) networks for temporal pattern recognition. In order to forecast the start of moderate cognitive impairment months before conventional clinical criteria could be satisfied, the main goal was to train these AI models to recognize minute variations from each person’s unique baseline. Important Results (Hypothetical) With a 92% prediction accuracy, the AI-driven study was able to identify a multivariate biomarker profile associated with early cognitive deterioration. Importantly, the system was able to identify temporary changes in everyday activities, such as increased nocturnal wandering and entropy changes in spoken language, long before carers noticed them or could measure them using conventional paper-and-pencil exams. Real-time anomaly notifications made possible by the incorporation of edge computing enabled prompt triage and focused clinical evaluation. Conclusion The neuro-sensing grid underlines how important AI-powered IoT is to revolutionizing research on brain health. This technique provides a reliable, scalable, and non-invasive method for personalized neuro-surveillance by moving the locus of assessment from the clinic to the lived environment. This opens the door for truly preventive therapies against age-related cognitive decline.